| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
BALTIMORE—Despite the elucidation of the human genome, most efforts to understand genetic changes in cancer have focused on only a handful of marker genes. Because cancer pathology is more widespread than the effects of one or two genes, researchers from Johns Hopkins Medical Institutions, Agencourt Bioscience, SoftGenetics and other institutes recently performed a systematic analysis of two cancers to identify secondary genes involved in the diseases.
 
They presented their work in Science.
 
The researchers focused their efforts on identifying mutations in the protein-coding subset of genes, using PCR, sequencing and bioinformatics to examine more than 120,000 sequences (13,023 genes) in 11 strains each of breast and colorectal cancer cells. Of the almost 900,000 mutations they identified, the researchers noted a subset of 186 genes, which they called CAN-genes, that closely correlated with disease.
 
None of the genes—involved in processes ranging from gene expression to cell adhesion to cell invasion—was previously associated with cancer progression, making them attractive targets for future therapeutics and diagnostics development. The results also suggest the importance of performing similar large-scale genomic analyses for other genetic diseases.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue